{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-009274","form_type":"8-K","ticker":"FENC","cik":"0001211583","company_name":"FENNEC PHARMACEUTICALS INC.","filed_at":"2022-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.612382+00:00","generated_at":"2026-06-27T13:26:30.068843+00:00","sec_items":["9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Fennec amends loan agreement with Bridge Bank; sets PEDMARK NDA resubmission and approval milestones","bullets":["Third Amendment to 2019 Loan & Security Agreement with Bridge Bank (Western Alliance Bank) dated Jan 27, 2022.","Defines 'Resubmission Event': resubmission of PEDMARK NDA to FDA on or before March 31, 2022.","Defines 'Approval Event': receipt of final NDA approval for PEDMARK on or before September 30, 2022.","Second Draw Period commences upon Approval Event; proceeds for commercial readiness prior to potential PEDMARK approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-009274","json":"https://secwatch.observer/filing/0001104659-22-009274.json","markdown":"https://secwatch.observer/filing/0001104659-22-009274.md","text":"https://secwatch.observer/filing/0001104659-22-009274.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1211583/000110465922009274/0001104659-22-009274-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1211583/000110465922009274/tm224898d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T13:26:30.068843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}